Interestingly, our study also showed enhanced ICAM-1 levels in patients with SSc-ILD+ and IPF in relation to those with SSc-ILD−, evidencing a potential influence of lung vasculopathy on circulating ICAM-1. The gene discussed is ICAM1; the disease is systemic sclerosis.